diabetics

Diabetes Drug Januvia Has New FDA-Approved Uses

Filed in archive Developments , News , Treatment on October 26, 2007

Approved by the FDA in October 2006, the diabetes drug by Merck - Januvia (sitagliptin) - is a prescription medicine being used as part of a treatment programme (including diet and exercise) to lower blood sugar in patients with type 2 diabetes.

Diabetes Drug Januvia Has New FDA-Approved Uses



Januvia is administered either alone or as an adjunctive therapy with certain other drugs, such as metformin and thiazolidinediones.

Januvia is a DPP-4 inhibitor: it inhibits glucagon production (the enzyme that increases blood sugar), and stimulates insulin (the enzyme that decreases blood sugar).


Now, the FDA has approved new uses for Januvia:

  • could also be used in combination with sulfonylurea and metformin, in cases when the two are not enough to control blood sugar

  • could be used with metformin as an initial therapy



The above follow-up application of Januvia was supported by three studies on the safety and efficacy of Januvia.

Find more details from Medical News Today.



Permalink: Diabetes Drug Januvia Has New FDA-Approved Uses

Tags: Januvia  type  2  diabetes  metformin  thiazolidinediones  sulfonylurea  januvia  diabetes+drug 

Vote for Diabetes Drug Januvia Has New FDA-Approved Uses:

  • Currently 7.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.50 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Most Popular   Best of   Blogs, Blogging & Blogosphere   Challenges   Developments   Diabetics' Device   Did you know   Diet   Education   Exercise   Family Matters   Friends   Fun   Information   Information about   Inspiration   Interviews   Lifestyle   Misc   News   Notable